表紙
市場調查報告書

全球介入性X光的碘顯影劑市場:產業趨勢及至2027年的預測

Global Iodinated Contrast Media in Interventional X-Ray Market - Industry Trends and Forecast To 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 919210
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
全球介入性X光的碘顯影劑市場:產業趨勢及至2027年的預測 Global Iodinated Contrast Media in Interventional X-Ray Market - Industry Trends and Forecast To 2027
出版日期: 2019年12月01日內容資訊: 英文
簡介

全球介入性X光的碘顯影劑市場在2020年∼2027年間,預測將以5.3%的年複合成長率成長。

本報告提供全球介入性X光的碘顯影劑市場的相關調查,市場機會和課題,各成長及阻礙因素給藥途徑、終端用戶、適應症、藥物類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查的目的
  • 市場定義
  • 市場概要
  • 限制事項
  • 對象市場

第2章 市場區隔

  • 對象市場
  • 地理範圍
  • 調查考慮年份
  • 貨幣、價格
  • DBMR TRIPOD DATA VALIDATION MODEL
  • 多事變數量建模
  • 主要意見領袖的主要會談
  • 應用電網
  • DBMR MARKET POSITION GRID
  • 廠商市場佔有率分析
  • 第二手資料
  • 前提條件

第3章 市場概況

  • 成長要素
    • 碘劑的多數的認證
    • 高齡化人口的增加
    • 慢性疾病的增加
    • 顯影劑的研究活動增加
  • 阻礙因素
    • 顯影劑的高成本
    • 顯影劑相關的副作用
  • 市場機會
    • 醫療保健基礎設施的成長
    • 市場參與企業的策略性舉措
    • 診斷中心數的增加
    • 今後的非專利顯影劑
  • 課題
    • 顯影劑的恰當劑量相關認識不足
    • 線形釓為基礎的顯影劑的限制及撤回

第4章 摘要整理

第5章 重要的洞察

第6章 市場分析:各給藥途徑

  • 概要
  • 靜脈內
  • 口服
  • 直腸
  • 其他

第7章 市場分析:各終端用戶

  • 概要
  • 醫院
  • 專門診所
    • 成像中心
    • 開業醫生
  • 診斷中心
  • 移動手術中心
  • 研究機關及學術機構

第8章 市場分析:各適應症

  • 概要
  • 循環系統
    • 經皮冠狀動脈疾病
    • 結構的心臟疾病
    • 先天性心臟病
    • 電生理學
  • 神經學
  • 一般手術
  • 腫瘤學
  • 泌尿系統

第9章 市場分析:各藥物類型

  • 概要
  • 非離子
  • 離子

第10章 市場分析:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 瑞士
    • 荷蘭
    • 俄羅斯
    • 比利時
    • 土耳其
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 菲律賓
    • 亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 秘魯
    • 其他
  • 中東、非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 埃及
    • 南非
    • 以色列
    • 其他

第11章 競爭情形

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第12章 企業簡介

  • BRACCO DIAGNOSTIC INC.
    • 企業概要
    • 企業的佔有率分析
    • 產品系列
    • 最近的開發
  • GENERAL ELECTRIC
  • GUERBET
  • BAYER AG
  • IMAX
  • ISO-TEX DIAGNOSTICS, INC.
  • J.B.CHEMICALS AND PHARMACEUTICALS LTD.
  • NOVALEK PHARMACEUTICALS PVT. LTD.
  • TAEJOON PHARM
  • UNIJULES LIFE SCIENCES LTD.

第13章 問卷調查

第14章 相關報告

目錄

Global iodinated contrast media in interventional X-ray market is projected to register a substantial CAGR of 5.3 % in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

By Route of Administration (Intravenous, Oral, Rectal, Others), Indication (Cardiology, Neurology, General Surgery, Oncology, Urology), Agent Type (Non-Ionic, Ionic), End User (Hospital, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research & Academic Institutes), Country ( U.S., Canada, Mexico,, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Russia, Belgium, Turkey, Rest Of Europe, China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, UAE, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Market Trends and Forecast to 2027

Some of the major factors contributing to the growth of the market are:

  • Increasing health care expenditure
  • Increasing genetic population

Key Market Players

The key market players for global iodinated contrast media in interventional X-ray market are listed below:

  • Bayer AG
  • Iso-Tex Diagnostics, Inc.
  • Bracco Diagnostic Inc.
  • Novalek Pharmaceuticals Pvt. Ltd.
  • iMAX
  • Taejoon Pharm
  • Unijules Life Sciences Ltd
  • General Electric
  • Guerbet LLC
  • J.B.Chemicals & Pharmaceuticals Ltd

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.8 APPLICATION GRID
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTION

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 LARGE NUMBER OF APPROVALS FOR IODINATED AGENTS
    • 3.1.2 RISING AGING POPULATION
    • 3.1.3 INCREASING NUMBER OF CHRONIC DISEASES
    • 3.1.4 INCREASING RESEARCH ACTIVITIES FOR CONTRAST AGENTS
  • 3.2 RESTRAINTS
    • 3.2.1 HIGH COST OF CONTRAST MEDIA
    • 3.2.2 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS
  • 3.3 OPPORTUNITIES
    • 3.3.1 GROWING HEALTHCARE INFRASTRUCTURE
    • 3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS
    • 3.3.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
    • 3.3.4 UPCOMING GENERIC CONTRAST MEDIA AGENTS
  • 3.4 CHALLENGES
    • 3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT
    • 3.4.2 RESTRICTION AND WITHDRAWAL OF LINEAR GADOLINIUM-BASED CONTRAST AGENTS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION

  • 6.1 OVERVIEW
  • 6.2 INTRAVENOUS
  • 6.3 ORAL
  • 6.4 RECTAL
  • 6.5 OTHERS

7 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITAL
  • 7.3 SPECIALTY CLINICS
    • 7.3.1 IMAGING CENTERS
    • 7.3.2 PRIVATE PRACTICES
  • 7.4 DIAGNOSTIC CENTERS
  • 7.5 AMBULATORY SURGICAL CENTERS
  • 7.6 RESEARCH & ACADEMIC INSTITUTES

8 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION

  • 8.1 OVERVIEW
  • 8.2 CARDIOLOGY
    • 8.2.1 PERCUTANEOUS CORONARY DISEASE
    • 8.2.2 STRUCTURAL HEART DISEASE
    • 8.2.3 CONGENITAL HEART DISEASE
    • 8.2.4 ELECTROPHYSIOLOGY
  • 8.3 NEUROLOGY
  • 8.4 GENERAL SURGERY
  • 8.5 ONCOLOGY
  • 8.6 UROLOGY

9 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE

  • 9.1 OVERVIEW
  • 9.2 NON-IONIC
  • 9.3 IONIC

10 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 U.S.
    • 10.2.2 CANADA
    • 10.2.3 MEXICO
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 U.K.
    • 10.3.3 FRANCE
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 SWITZERLAND
    • 10.3.7 NETHERLANDS
    • 10.3.8 RUSSIA
    • 10.3.9 BELGIUM
    • 10.3.10 TURKEY
    • 10.3.11 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 JAPAN
    • 10.4.3 SOUTH KOREA
    • 10.4.4 INDIA
    • 10.4.5 AUSTRALIA
    • 10.4.6 SINGAPORE
    • 10.4.7 THAILAND
    • 10.4.8 MALAYSIA
    • 10.4.9 INDONESIA
    • 10.4.10 PHILIPPINES
    • 10.4.11 REST OF ASIA-PACIFIC

  • 10.5 SOUTH AMERICA
    • 10.5.1 BRAZIL
    • 10.5.2 ARGENTINA
    • 10.5.3 PERU
    • 10.5.4 REST OF SOUTH AMERICA
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 U.A.E.
    • 10.6.2 SAUDI ARABIA
    • 10.6.3 EGYPT
    • 10.6.4 SOUTH AFRICA
    • 10.6.5 ISRAEL
    • 10.6.6 REST OF MIDDLE EAST & AFRICA

11 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE

  • 11.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 11.3 COMPANY SHARE ANALYSIS: EUROPE
  • 11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 COMPANY PROFILES

  • 12.1 BRACCO DIAGNOSTIC INC.
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 COMPANY SHARE ANALYSIS
    • 12.1.3 PRODUCT PORTFOLIO
    • 12.1.4 RECENT DEVELOPMENT
  • 12.2 GENERAL ELECTRIC
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENTS
  • 12.3 GUERBET
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 REVENUE ANALYSIS
    • 12.3.3 COMPANY SHARE ANALYSIS
    • 12.3.4 PRODUCT PORTFOLIO
    • 12.3.5 RECENT DEVELOPMENT

  • 12.4 BAYER AG
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 REVENUE ANALYSIS
    • 12.4.3 PRODUCT PORTFOLIO
    • 12.4.4 RECENT DEVELOPMENT
  • 12.5 IMAX
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 PRODUCT PORTFOLIO
    • 12.5.3 RECENT DEVELOPMENT
  • 12.6 ISO-TEX DIAGNOSTICS, INC.
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 PRODUCT PORTFOLIO
    • 12.6.3 RECENT DEVELOPMENT
  • 12.7 J.B.CHEMICALS AND PHARMACEUTICALS LTD.
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 REVENUE ANALYSIS
    • 12.7.3 PRODUCT PORTFOLIO
    • 12.7.4 RECENT DEVELOPMENT
  • 12.8 NOVALEK PHARMACEUTICALS PVT. LTD.
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 PRODUCT PORTFOLIO
    • 12.8.3 RECENT DEVELOPMENT
  • 12.9 TAEJOON PHARM
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 PRODUCT PORTFOLIO
    • 12.9.3 RECENT DEVELOPMENT
  • 12.10 UNIJULES LIFE SCIENCES LTD.
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 PRODUCT PORTFOLIO
    • 12.10.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS
  • TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS
  • TABLE 3 COST OF CONTRAST MEDIA
  • TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS
  • TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT'S WEIGHT
  • TABLE 6 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 GLOBAL AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 GLOBAL RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 19 GLOBAL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20 GLOBAL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 21 GLOBAL NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22 GLOBAL GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23 GLOBAL ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 GLOBAL UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 26 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)
  • TABLE 27 GLOBAL NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28 GLOBAL IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAYS MARKET, BY GEOGRAPHY, 2018-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 31 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 33 NORTH AMERICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 34 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 35 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 36 NORTH AMERICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 37 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 38 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 39 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 40 U.S. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 41 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 42 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 43 U.S. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 44 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 45 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 46 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 47 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 48 CANADA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 49 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 50 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 51 CANADA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 52 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 53 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 54 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 55 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 56 MEXICO CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 57 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 58 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 59 MEXICO SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 60 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 61 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 62 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 63 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 64 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 65 EUROPE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 66 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 67 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 68 EUROPE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 69 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 70 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 71 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 72 GERMANY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 73 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 74 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 75 GERMANY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 76 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 77 GERMANY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 78 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 79 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 80 U.K. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 81 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 83 U.K. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 84 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 85 U.K. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 86 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 87 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 88 FRANCE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 89 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 90 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 91 FRANCE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 92 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 93 FRANCE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 94 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 95 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 96 ITALY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 97 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 98 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 99 ITALY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 100 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 101 ITALY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 102 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 103 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 104 SPAIN CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 105 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 106 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 107 SPAIN SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 108 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 109 SPAIN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 110 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 111 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 112 SWITZERLAND CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 113 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 114 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 115 SWITZERLAND SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 116 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 117 SWITZERLAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 118 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 119 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 120 NETHERLANDS CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 121 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 122 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 123 NETHERLANDS SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 124 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 125 NETHERLANDS IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 126 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 127 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 128 RUSSIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 129 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 130 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 131 RUSSIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 132 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 133 RUSSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 134 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 135 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 136 BELGIUM CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 137 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 138 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 139 BELGIUM SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 140 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 141 BELGIUM IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 142 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 143 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 144 TURKEY CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 145 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 146 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 147 TURKEY SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 148 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 149 TURKEY IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 150 REST OF EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 151 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 152 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 153 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 154 ASIA-PACIFIC CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 155 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 156 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 157 ASIA-PACIFIC SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 158 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 159 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 160 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 161 CHINA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 162 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 163 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 164 CHINA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 165 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 166 CHINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 167 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 168 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 169 JAPAN CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 170 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 171 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 172 JAPAN SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 173 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 174 JAPAN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 175 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 176 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 177 SOUTH KOREA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 178 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 179 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 180 SOUTH KOREA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 181 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 182 SOUTH KOREA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 183 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 184 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 185 INDIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 186 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 187 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 188 INDIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 189 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 190 INDIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 191 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 192 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 193 AUSTRALIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 194 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 195 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 196 AUSTRALIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 197 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 198 AUSTRALIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 199 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 200 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 201 SINGAPORE CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 202 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 203 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 204 SINGAPORE SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 205 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 206 SINGAPORE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 207 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 208 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 209 THAILAND CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 210 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 211 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 212 THAILAND SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 213 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 214 THAILAND IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 215 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 216 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 217 MALAYSIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 218 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 219 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 220 MALAYSIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 221 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 222 MALAYSIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 223 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 224 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 225 INDONESIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 226 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 227 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 228 INDONESIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 229 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 230 INDONESIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 231 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 232 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 233 PHILIPPINES CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 234 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 235 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 236 PHILIPPINES SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 237 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 238 PHILIPPINES IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 239 REST OF ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 240 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 241 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 242 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 243 SOUTH AMERICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 244 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 245 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 246 SOUTH AMERICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 247 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 248 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 249 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 250 BRAZIL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 251 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 252 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 253 BRAZIL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 254 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 255 BRAZIL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 256 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 257 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 258 ARGENTINA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 259 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 260 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 261 ARGENTINA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 262 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 263 ARGENTINA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 264 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 265 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 266 PERU CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 267 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 268 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 269 PERU SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 270 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 271 PERU IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 272 REST OF SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 273 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 274 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 275 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 276 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 277 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 278 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 279 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 280 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 281 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 282 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 283 U.A.E. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 284 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 285 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 286 U.A.E. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 287 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 288 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 289 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 290 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 291 SAUDI ARABIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 292 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 293 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 294 SAUDI ARABIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 295 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 296 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 297 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 298 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 299 EGYPT CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 300 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 301 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 302 EGYPT SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 303 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 304 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 305 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 306 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 307 SOUTH AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 308 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 309 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 310 SOUTH AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 311 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 312 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 313 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 314 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 315 ISRAEL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 316 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • TABLE 317 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 318 ISRAEL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 319 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)
  • TABLE 320 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))
  • TABLE 321 REST OF MIDDLE EAST & AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET
  • FIGURE 10 AGEING POPULATION IN ASIA-PACIFIC (IN MILLION)
  • FIGURE 11 AGEING POPULATION IN EUROPE (IN MILLION)
  • FIGURE 12 AGEING POPULATION IN NORTH AMERICA (IN MILLION)
  • FIGURE 13 WORLD'S AGING POPULATION BY AGE GROUP AND SEX, IN 2017
  • FIGURE 14 WORLD'S AGING POPULATION BY AGE GROUP AND SEX, IN 2050
  • FIGURE 15 AGEING WORLD POPULATION (NUMBER OF PERSONS AGED 60 YEARS OR OLDER IN MILLIONS)
  • FIGURE 16 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
  • FIGURE 17 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SEGMENTATION
  • FIGURE 18 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 19 LARGE NUMBER OF APPROVALS FOR IODINATED AGENTS AND INCREASING NUMBER OF CHRONIC DISEASES IS DRIVING THE GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 20 INTRAVENOUS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET IN 2020 & 2027
  • FIGURE 21 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 22 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2019
  • FIGURE 23 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • FIGURE 24 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, CAGR (2020-2027)
  • FIGURE 25 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
  • FIGURE 26 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2019
  • FIGURE 27 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • FIGURE 28 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, CAGR (2020-2027)
  • FIGURE 29 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, LIFELINE CURVE
  • FIGURE 30 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2019
  • FIGURE 31 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)
  • FIGURE 32 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, CAGR (2020-2027)
  • FIGURE 33 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, LIFELINE CURVE
  • FIGURE 34 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2019
  • FIGURE 35 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)
  • FIGURE 36 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, CAGR (2020-2027)
  • FIGURE 37 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, LIFELINE CURVE
  • FIGURE 38 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SNAPSHOT (2019)
  • FIGURE 39 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY GEOGRAPHY (2019)
  • FIGURE 40 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY GEOGRAPHY (2020 & 2027)
  • FIGURE 41 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY GEOGRAPHY (2019 & 2027)
  • FIGURE 42 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY ROUTE OF ADMINISTARTION (2020-2027)
  • FIGURE 43 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SNAPSHOT (2019)
  • FIGURE 44 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019)
  • FIGURE 45 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 46 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 47 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY ROUTE OF ADMINISTARTION (2020-2027)
  • FIGURE 48 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SNAPSHOT (2019)
  • FIGURE 49 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019)
  • FIGURE 50 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 51 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 52 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY TREATMENT (2020- 2027)
  • FIGURE 53 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SNAPSHOT (2019)
  • FIGURE 54 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019)
  • FIGURE 55 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 56 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 57 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY ROUTE OF ADMINISTRATION (2020-2027)
  • FIGURE 58 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SNAPSHOT (2019)
  • FIGURE 59 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019)
  • FIGURE 60 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 61 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 62 SOUTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY ROUTE OF ADMINISTRATION (2020-2027)
  • FIGURE 63 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: SNAPSHOT (2019)
  • FIGURE 64 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019)
  • FIGURE 65 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 66 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 67 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: BY ROUTE OF ADMINISTRATION (2020-2027)
  • FIGURE 68 GLOBAL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 69 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 70 EUROPE IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 71 ASIA-PACIFIC IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2019 (%)
Back to Top